MIssling is a gambler that lost. Instead of conservative belt and suspenders trials, he tried to go cheap and gamble that a small trial would be accepted. Fed shareholders a bunch of BS to hide this risky approach. Now the 273 patents are losing billions in sales each year of delay, worth less and less. Soon the runway of patent protection will be so short that no BP will be interested. Should be putting a full court press for a partner who can fund alz, PD and epilepsy trials simultaneously. 50% dilution would be worth it at this stage if the above could be achieved.
Market Data 
Markets 
